Global Capital Markets Ratios

Global Capital Markets Ltd Ratios

The Global Capital Markets Ltd Ratios page provides a complete fundamental analysis of Global Capital Markets Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Global Capital Markets Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Global Capital Markets Ltd (NSE: , BSE: 530263) is currently trading at ₹0.52, with a market capitalization of ₹207.11M. As a major player in the Finance sector and Financial conglomerates industry, Global Capital Markets Ltd remains a key stock for fundamental analysis using Global Capital Markets Ltd Ratios.

Global Capital Markets Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Global Capital Markets Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Global Capital Markets Ltd Ratios.

Historically, the Global Capital Markets Ltd P/E ratio has shown strong fluctuations:

• 2024: 0
• 2023: 8300
• 2022: 0
• 2021: 11.89
• 2020: 9.48

The decline in Global Capital Markets Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Global Capital Markets Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.63.

Historical P/B trend:

• 2024: 0.63
• 2023: 0.72
• 2022: 1.45
• 2021: 0.23

Global Capital Markets Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Global Capital Markets Ltd P/S ratio currently stands at 11.58, an important part of Global Capital Markets Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 11.58
• 2023: 34.31
• 2022: 3.65
• 2021: 2.55

A stable or declining Global Capital Markets Ltd P/S ratio indicates cautious market sentiment.

Global Capital Markets Ltd Price to Cash Flow Ratio (P/CF)

The Global Capital Markets Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 5.36.

Historical Global Capital Markets Ltd Price to Cash Flow Ratio:

• 2024: 5.36
• 2023: 0
• 2022: 0
• 2021: 2.32
• 2020: 0

The rising Global Capital Markets Ltd Price to Cash Flow Ratio indicates premium valuation based on cash flow.

Global Capital Markets Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Global Capital Markets Ltd EV currently stands at ₹278.69M, representing the total company valuation including debt.

Historical EV trend:

• 2024: 278.69M
• 2023: 299.22M
• 2022: 687.02M
• 2021: 115.42M

Global Capital Markets Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Global Capital Markets Ltd EV/EBITDA ratio is currently 0, a key metric in Global Capital Markets Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 0
• 2023: 333.20
• 2022: 1380
• 2021: 10.94

Stable Global Capital Markets Ltd EV/EBITDA indicates balanced valuation.

Global Capital Markets Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Global Capital Markets Ltd D/E ratio is currently 0, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

Global Capital Markets Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Global Capital Markets Ltd ROE currently stands at -1.87%, showing profitability and capital efficiency.

Historical ROE:

• 2024: -1.87
• 2023: 0.01
• 2022: -0.35
• 2021: 1.92

Declining ROE indicates pressure on profitability.

Global Capital Markets Ltd Ratios Analysis Summary

The Global Capital Markets Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Global Capital Markets Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Global Capital Markets Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.